- Home
- HAFC vs LENZ Comparison
HAFC vs LENZ Comparison
Compare HAFC & LENZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HAFC | LENZ |
|---|---|---|
| Founded | 1982 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 758.9M | 852.0M |
| IPO Year | 1996 | 2021 |
Fundamental Metrics
Financial Performance| Metric | HAFC | LENZ |
|---|---|---|
| Price | $29.18 | $24.34 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 4 |
| Target Price | $28.50 | ★ $56.25 |
| AVG Volume (30 Days) | 172.8K | ★ 868.1K |
| Earning Date | 01-27-2026 | 11-05-2025 |
| Dividend Yield | ★ 3.80% | N/A |
| EPS Growth | ★ 15.36 | N/A |
| EPS | ★ 2.40 | N/A |
| Revenue | ★ $246,352,000.00 | $17,500,000.00 |
| Revenue This Year | $19.61 | N/A |
| Revenue Next Year | $11.05 | $204.72 |
| P/E Ratio | $11.83 | ★ N/A |
| Revenue Growth | ★ 5.84 | N/A |
| 52 Week Low | $19.25 | $16.54 |
| 52 Week High | $29.13 | $50.40 |
Technical Indicators
Market Signals| Indicator | HAFC | LENZ |
|---|---|---|
| Relative Strength Index (RSI) | 71.57 | 35.63 |
| Support Level | $28.00 | $27.07 |
| Resistance Level | $29.27 | $29.02 |
| Average True Range (ATR) | 0.60 | 1.97 |
| MACD | 0.09 | -0.16 |
| Stochastic Oscillator | 95.25 | 5.06 |
Price Performance
Historical ComparisonAbout HAFC Hanmi Financial Corporation
Hanmi Financial Corp is a Los Angeles-based bank that caters to Korean-Americans and other multi-ethnic communities across California, Colorado, Georgia, Illinois, New Jersey, New York, Texas, Virginia, and Washington. The bank mainly focuses on small businesses and commercial and real estate loans. It also offers a variety of international finance and trade services and products, including letters of credit, import financing, and export financing. The Bank's revenues are derived from interest and fees on loans, interest, and dividends on the securities portfolio, service charges on deposit accounts, and sales of SBA loans.
About LENZ LENZ Therapeutics Inc.
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.